Center for HIV/AIDS Care & Research at BMC

Center for HIV/AIDS Care & Research

Text Size Increase Text Size Decrease Font Size Print Page


Research within the CHACR focuses on events that influence HIV infection and lead to the progression of AIDS, with the goal of discovering ways to prevent progression and to help people stay healthy.

Basic research projects include identification of viral cellular mechanisms that regulate key steps of the HIV life cycle to discover new therapeutic targets. An understanding of how HIV interferes with the host immune response, particularly innate immunity, to allow AIDS-associated infections of different tissues, including muscle, lung and brain, is a major goal of CHACR investigators. Seminars and research-in-progress discussion groups sponsored by the CHACR bring together faculty and promote collaborations across sections, departments and schools with a broad range of research interests, assuring a multidisciplinary approach to basic, translational and clinical research related to HIV and AIDS.

Clinical research is an important aspect of caring for HIV patients. While there are more treatment options than ever before, the need for new and improved medications and treatment options remain critical. The best ways to combine and use these therapies is an important area of study. The CHACR clinical research staff is dedicated to providing the latest treatments to patients with HIV infection. The majority of clinical studies conducted in the CHACR are national or international multi-centered trials. Many of the trials involve investigational drugs that allow patients access to novel therapies not generally available to the public. Patients also feel personal satisfaction by contributing to increased knowledge about how best to treat HIV infection.

In addition to participating in studies involving investigational drugs, the CHACR is a clinical research site of the Adult AIDS Clinical Trials Group (AACTG). The AACTG is the largest HIV clinical trials organization, both nationally and internationally. It plays a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV/AIDS in the United States and abroad. The AACTG is composed of, and directed by, leading clinician-scientists in HIV/AIDS therapeutics research. The AACTG is funded by the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID).

Principal Investigators & Collaborators

Research Interests

Paul R. Skolnik, MD
Professor of Medicine
Director, Center for HIV/AIDS Care and Research
Section of Infectious Diseases
Innate immunity in the lung; modeling of cytokine and chemokine networks in the lung; investigational HIV drug trials; patient-oriented HIV immunopathogenesis studies
Ioana Bica, MD
Assistant Professor of Medicine
Section of Infectious Diseases
HIV-HCV co-infection
Jon D. Fuller, MD
Associate Professor of Medicine
Section of Infectious Diseases
HIV therapeutics; ethics of HIV prevention; delivery of international care
Davidson H. Hamer, MD
Associate Professor of International Health
Boston University School of Public Health
Associate Professor of Medicine
Section of Infectious Diseases
HIV therapeutics
Hélène Hardy, PharmD
Adjunct Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Clinical and Research Pharmacist
Section of Infectious Diseases
Adherence; HIV therapeutics
Andrew J. Henderson, PhD
Associate Professor of Medicine
Section of Infectious Diseases
Associate Professor of Microbiology
Department of Microbiology
Cellular signals that regulate HIV transcription and regulation
Michael H. Ieong, MD
Assistant Professor of Medicine
Director, Pulmonary Function Laboratory
Section of Pulmonary, Allergy and Critical Care Medicine
HIV pathogenesis in the lung; redox cell signaling pathways; alveolar macrophage biology; innate immunity of the lung
Monty A. Montano, PhD
Assistant Professor of Medicine
Section of Infectious Diseases
Immuno-genomics of HIV infection and pathogenesis; muscle stem cell biology and wasting; aging
Stephen I. Pelton, MD
Professor of Pediatrics
Department of Pediatric Infectious Diseases
HIV; Hepatitis C virus and disease; Pneumococcal vaccines and diseases; immune function
Margaret M. Sullivan, MD
Assistant Professor of Medicine
Section of Infectious Diseases
Mother-to-child transmission of HIV; assisted reproduction for serodiscordant couples
Thomas E. Van Dyke, DMD
Professor of Oral Biology and Periodontology
Director, Clinical Research Center
Boston University Goldman School of Dental Medicine
Catherine Yu, MD
Assistant Professor of Medicine
HIV in the elderly


Call: 617.414.4290
Fax: 617.414.4285

STD Program

Call: 617.414.4290, option #3
STD Hotline: 617.414.4081

Boston Medical Center
Center for Infectious Diseases
Dowling Building
Ground Floor
850 Harrison Avenue
Boston, MA 02118

HIV Testing/Project TRUST

Walk-in Service / No Appointment Necessary
Call: 617.414.4495

721 Massachusetts Ave
Boston, MA 02118
M– F, 8:30 am – 5:00 pm
Testing available 9 am – 4 pm

Refer a Patient

Call: 617.414.4290
Fax: 617.414.4285

Administration Offices

Center for HIV/AIDS Care & Research
Dowling Building, 3rd Floor
771 Albany Street
Boston, MA 02118
Call: 617.414.7059
Fax: 617.638.8070

Evans Biomedical Research Center
650 Albany Street, 6th Floor
Boston, MA 02118
Call: 617.414.3504
Fax: 617.414.5283

Learn More

Quick Links

Center for Infectious Diseases
Directions to BMC
HIV Testing/Project Trust
Walk-in STD Clinic

Downloads (PDF)

BMC Campus Map
What Makes BMC Special

Go to Top ^